Epidemiology, Risk Factors, and Clinical Profile of COVID-19 Associated Mucormycosis: Lessons Learned and Future Strategies

Dr. Tejas Gopalkrishnan, Dr. Poojan Thakkar, Dr. Shoyeb Shaikh, Dr. Rahul Gupta, Dr. RG Aiyer, Dr. Saransh Narang, Dr. Chetna Hirani, Dr. Kajal Patel, Dr. Preksha Jain

Abstract: This comprehensive study delves into the epidemiological patterns, risk factors, and clinical manifestations of COVID-19 Associated Mucormycosis CAMCR during the pandemic, shedding light on critical insights and lessons for future healthcare strategies. Analyzing data from a single institution, predominantly from Gujarat, India, this research underscores the prominent role of steroids in CAMCR development, emphasizing the need for prudent steroid usage and diligent glycemic control. Additionally, it explores potential contributing factors such as oxygen therapy, tocilizumab, remdesivir, and broad-spectrum antibiotics. The study highlights the necessity of strengthened primary healthcare, awareness campaigns, and rigorous monitoring to prevent this devastating condition. Through a multidisciplinary approach, this research aims to inform healthcare practitioners and policymakers about CAMCRs complexities and provide a roadmap for prevention and management in future healthcare crises.

Keywords: Epidemiology, COVID-19 Associated Mucormycosis, Risk Factors, Clinical Profile, Steroid Usage, Glycemic Control, Oxygen Therapy, Primary Healthcare, Awareness Campaigns, Multidisciplinary Approach

How to Cite?: Dr. Tejas Gopalkrishnan, Dr. Poojan Thakkar, Dr. Shoyeb Shaikh, Dr. Rahul Gupta, Dr. RG Aiyer, Dr. Saransh Narang, Dr. Chetna Hirani, Dr. Kajal Patel, Dr. Preksha Jain, "Epidemiology, Risk Factors, and Clinical Profile of COVID-19 Associated Mucormycosis: Lessons Learned and Future Strategies", Volume 12 Issue 10, October 2023, International Journal of Science and Research (IJSR), Pages: 1854-1862, https://www.ijsr.net/getabstract.php?paperid=SR23926184231, DOI: https://dx.doi.org/10.21275/SR23926184231